Mobile

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Explore the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients with Refractory Partial Seizures

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003702-26

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to determine the tolerability of doses up to a maximum of 12 mg per day of E2007 in patients with refractory partial seizures who are taking inducing and noninducing anti-epileptic drugs (AEDs).

Critère d'inclusion

  • Refractory Partial Seizures

Liens